drugs

Paul Hastings and Freshfields lead as Fosun strikes $135m deal for COVID-19 vaccine

Paul Hastings, Freshfields Bruckhaus Deringer, Stephenson Harwood and Covington & Burling formed the legal lineup behind Fosun Pharma’s $135m (£113.7) deal with Germany’s BioNtech, in the hunt for a COVID-19 vaccine. Shanghai Fosun Pharmaceutical (Group) is advised by Paul Hastings. The US firm’s team is led by Shanghai-based corporate partner Jia Yan, who is also […]